Dapivirine ring for women’s HIV prevention receives WHO prequalification – Medical Xpress

The nonprofit International Partnership for Microbicides (IPM) is pleased to announce the World Health Organization’s (WHO) prequalification of the dapivirine ring, a monthly vaginal ring to reduce women’s HIV risk.
This designation from the WHO confirms that the ring meets global standards for quality, safety and efficacy. The product’s addition to the WHO’s list of prequalified medicines will help guide national and global procurement decisions, pending country regulatory approvals for its use….

Click here to view the original article.